Urinary 6‐sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels
- 9 November 2005
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 40 (2) , 116-124
Abstract
Abstract: Exposure to light at night, as experienced by rotating night shift workers, has been related to lower circulating levels of melatonin, a hormone with recognized cancer protective properties. However, little is known about the relationship of other lifestyle factors or endogenous sex steroid hormones with melatonin levels. We examined cross‐sectional associations of age, reproductive and menopausal factors, body mass index (BMI), alcohol consumption, smoking history, night shift work, as well as several other breast cancer risk factors, and circulating sex steroid hormone levels with creatinine‐adjusted morning urinary melatonin (6‐sulfatoxymelatonin, aMT6s) levels. Participants were 459 healthy, primarily premenopausal (age range 33–50 yr) women from the Nurses’ Health Study II (NHS II). Using multiple linear regression, we computed least‐square mean hormone levels across categories of lifestyle factors. Age was inversely related to aMT6s levels, particularly before menopause (premenopausal women, ≤39 yr versus ≥49 yr; aMT6s, 20.8 ng/mg versus 11.8 ng/mg creatinine; P for trend, 0.02). In multivariate analyses, BMI was significantly and inversely associated with aMT6s levels (P for trend, P for trend, 0.04). We also observed a positive association between parity and aMT6s levels (P for trend, <0.01), but no other reproductive factors nor any of the sex hormones (estradiol, progesterone, estrone, estrone sulfate, dehydroepiandrostenedione, dehydroepiandrostenedione sulfate, testosterone, and androstenedione), as measured either in the luteal or the follicular phase of the menstrual cycle, were significantly associated with aMT6s. In conclusion, higher age, BMI, and heavy smoking were significantly related to lower levels of melatonin, whereas parity was significantly associated with higher aMT6s levels. Melatonin levels may be one mechanism through which these factors influence the development of cancer, but more studies are needed to elucidate these mechanisms definitively.Keywords
This publication has 55 references indexed in Scilit:
- Does melatonin induce apoptosis in MCF‐7 human breast cancer cells in vitro?Journal of Pineal Research, 2002
- Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitroLife Sciences, 1999
- Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiologyReviews of Reproduction, 1998
- Melatonin inhibits dna synthesis in mcf-7 human breast cancer cells in vitroLife Sciences, 1996
- Reproducibility and Validity of a Self-Administered Physical Activity QuestionnaireInternational Journal of Epidemiology, 1994
- Lowered Circannual Urinary Melatonin Concentrations in Episodic Cluster HeadacheCephalalgia, 1994
- Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatoninEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Antiproliferative effect of pineal indoles on cultured tumor cell linesJournal of Pineal Research, 1993
- Percentage Points for a Generalized ESD Many-Outlier ProcedureTechnometrics, 1983
- Light Suppresses Melatonin Secretion in HumansScience, 1980